跳至主要内容
临床试验/NCT06338384
NCT06338384尚未招募不适用

A Study of Peripheral Neuropathy Clinical Trial Experiences: Insights From Patients

Power Life Sciences Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年4月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Number of peripheral neuropathy patients who decide to enroll in a clinical research

研究概览

简要总结

This trial aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in peripheral neuropathy clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.

Ultimately, this trial endeavors to deepen our understanding of the factors impacting peripheral neuropathy clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥ 18 years old
  • Diagnosis of peripheral neuropathy
  • Able to comprehend the investigational nature of the protocol and provide informed consent

排除标准

  • Female patients who are currently pregnant or nursing
  • Inability to perform regular electronic reporting
  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

结局指标

主要结局

Number of peripheral neuropathy patients who decide to enroll in a clinical research

时间窗: 3 months

Rate of peripheral neuropathy patients who remain in clinical trial to trial completion

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part IIDepressionAnxiety Disorders
NCT05555875Brigham and Women's Hospital76
尚未招募
不适用
A Journey Into Participation Patterns Among Patients With Hidradenitis SuppurativaHidradenitis Suppurativa
NCT06201858Power Life Sciences Inc.500
已完成
不适用
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerRecurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus SarcomaStage I Uterine Corpus CancerStage I Uterine SarcomaStage IA Cervical CancerStage IB Cervical CancerStage II Uterine Corpus CancerStage II Uterine SarcomaStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage III Uterine Corpus CancerStage III Uterine SarcomaStage IV Uterine Corpus CancerStage IV Uterine SarcomaStage IVA Cervical CancerStage IVB Cervical Cancer
NCT01098630Gynecologic Oncology Group778
招募中
不适用
Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.Postherpetic NeuralgiaTrigeminal Neuralgia
NCT06290661Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60
已完成
不适用
Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal CancerPsychosocial Effects of Cancer and Its TreatmentColorectal CancerPancreatic Cancer
NCT00478010Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins205
Examining Engagement Trends Among Participants in... | 临床试验